![EP2582709B1 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases - Google Patents EP2582709B1 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases - Google Patents](https://patentimages.storage.googleapis.com/5c/ae/26/21fc506acb337e/imgb0095.png)
EP2582709B1 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases - Google Patents
![Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial - The Lancet Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/030c1ba7-bfbc-4f4f-920e-41f936073b04/gr2_lrg.jpg)
Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial - The Lancet
![Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial - The Lancet Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1c4ad784-bd20-414a-aa63-823d828c1632/gr1_lrg.gif)